Medical Robotics News

RSS

Pancreatic Cancer Risk Detected by AI-Based Model

An artificial intelligence (AI) model programmed using sequential health data extracted from electronic health records detected a subset of persons with a 25-fold danger of developing pancreatic cancer between 3 and 36 months, according to findings showcased at the 2022 Annual Meeting of the American Association for Cancer Research (AACR) that was held from April 8th to 13th.

11 Apr 2022

Study Shows How AI Technique Helps to Clean Single-Cell RNA-Sequencing Data

A single cell’s genome or transcriptome can reveal considerably more information about its role in living systems than sequencing a full batch of cells, much as interviewing a single person about their health can provide specialized, individualized information hard to obtain from a big poll.

8 Apr 2022

Study Shows How Abdominal CT Imaging Tool Helps to Treat Type 2 Diabetes

According to a new study published in the journal Radiology, researchers were able to detect early symptoms of type 2 diabetes on abdominal CT scans using a completely automated AI deep learning technique.

6 Apr 2022

H Robotics and Onesource Sports and Neuro Rehabilitation Partner to Expand in the US Market

H Robotics, experts in developing, manufacturing, and distributing state-of-the-art rehabilitation solutions, is pleased to announce their new partnership with Dr. Collin Adu of Onesource Sports & Neuro Rehabilitation. This new relationship plays an important role in H Robotic's expansion in the US market.

31 Mar 2022

AI Used in Breast Cancer Diagnosis, Likely to Be a Promising Approach

Artificial intelligence (AI) is a promising approach for breast cancer diagnosis in screening mammography programs, according to a major new study published in Radiology.

30 Mar 2022

Researchers Analyze the Accuracy of AI Used in Fracture Diagnosis

According to a study published in Radiology, artificial intelligence (AI) is an excellent tool for fracture identification that has the ability to help physicians in congested emergency rooms.

30 Mar 2022

Experts Identify Potential Dual-Purpose Therapeutic Targets for Aging and Age-Associated Diseases

Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced that it has developed a distinctive approach for recognizing potential dual-purpose therapeutic targets for aging and age-related diseases along with PandaOmics, its proprietary AI-enabled biological target discovery platform.

30 Mar 2022

Oxipit Receives CE Class IIb Certification for ChestLink Autonomous AI Imaging Suite

AI medical imaging application developer Oxipit was granted CE Class IIb certification for ChestLink autonomous AI imaging suite.

30 Mar 2022

AI-Based Robotic Platform Unveils Unique Signatures of Parkinson’s Disease

A study, appearing in the journal Nature Communications, reveals a new system for finding cellular signatures of disease that incorporates robotic platforms for analyzing patient cells with artificial intelligence (AI) approaches for image analysis.

28 Mar 2022

Research Shows How New AI Technique May Help to Treat Diabetes Patients

Hitachi, Ltd., University of Utah Health (U of U Health), and Regenstrief Institute, Inc. (Regenstrief) recently announced the development of artificial intelligence (AI) technology to enhance care for type 2 diabetes patients who require intensive treatment.

28 Mar 2022